Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 3

1.

Gemcitabine-based combination regimen in patients with peripheral T-cell lymphoma.

Dong M, He XH, Liu P, Qin Y, Yang JL, Zhou SY, Yang S, Zhang CG, Gui L, Zhou LQ, Shi YK.

Med Oncol. 2013 Mar;30(1):351. doi: 10.1007/s12032-012-0351-4. Epub 2012 Dec 27.

PMID:
23269584
2.

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Hagemeister FB.

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. Epub 2002 Apr 12. Review.

PMID:
12042984
3.

[Chemotherapy using gemcitabine hydrochloride for malignant lymphoma].

Asou H, Maeda K, Takeuchi K, Kiyosawa K, Taniai H.

Gan To Kagaku Ryoho. 2013 Nov;40(11):1489-95. Review. Japanese.

PMID:
24231701

Supplemental Content

Support Center